some fellow Italians created an interesting crispr targeted system that has a very small off target delivery
“This proof-of-principle study indicates that immunoliposome-based CRISPR delivery could offer a precise, non-toxic method for treating prostate cancer.”
fantastico!
Oxibendazole inhibits prostate cancer cell growth.Treatment-emergent small cell neuroendocrine prostate cancer.
Prostate Cancer Forum ZoomMicrobiome signatures in prostate cancer.
Long term AR signaling‐targeted therapy with taxane sometimes associated with visceral metastasis in castration‐resistant prostate cancer
